Resultados de la búsqueda 141-150 of 10601 for hra fsa eligible items

1. Hematología - Ensayos clínicos - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

2. Medicina Interna Hospitalaria - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to create an older adult registry from a primary care population and to identify patients who may be eligible for ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

6. Neurología - Ensayos clínicos

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

7. Neurología - Ensayos clínicos

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

9. Neurología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of investigational products for the treatment of ALS. ... Eligible patients with surgically ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. A Study ...